There was a favorable trend toward TMT in relapse-free survival (RFS), but the difference in 3-year RFS was not statistically significant (23.8% v. 45.2%, p = 0.45) 28 .
← all excerpts
Good prediction of treatment responses to neoadjuvant chemoradiotherapy for esophageal cancer based on preoperative inflammatory status and tumor glucose metabolism.
1
—
—